BSE Shares Rise 3% as F&O Weekly Expiry Changes Not on Sebi Agenda, Despite Potential Earnings Impact
Jefferies has cautioned about significant earnings reductions for BSE and Nuvama if SEBI implements changes to index derivatives expiry cycles. BSE could face a 20-50% EPS cut by FY2027, while Nuvama might see a 15-25% earnings decrease. Different scenarios were outlined: a fortnightly expiry could reduce BSE's earnings by 21-35% and Nuvama's by 15%, while a monthly expiry could impact BSE by 41-50% and Nuvama by 24%. Despite these warnings, BSE shares gained 2.70% following reports that long-term F&O contracts are not on SEBI's immediate agenda. The regulator has not officially confirmed any changes, and the market awaits SEBI's upcoming Board Meet for clarity.

*this image is generated using AI for illustrative purposes only.
Jefferies, a prominent global financial services firm, has issued a warning about potential significant earnings cuts for BSE (formerly Bombay Stock Exchange) and Nuvama, should the Securities and Exchange Board of India (SEBI) implement changes to the expiry cycle of index derivatives.
Potential Impact on Earnings
According to Jefferies' analysis, the proposed changes could have far-reaching consequences for both companies:
- BSE: The exchange could face a substantial 20-50% reduction in earnings per share (EPS) by fiscal year 2027.
- Nuvama: The financial services company might see a 15-25% decrease in earnings.
Scenario Analysis
Jefferies has outlined different scenarios based on potential changes to the derivative expiry cycle:
Fortnightly Expiry Cycle
- BSE: Earnings could drop by 21-35%, depending on the timing of expiry.
- Nuvama: A potential 15% impact on earnings.
Monthly Expiry Cycle
- BSE: A more severe impact with earnings potentially declining by 41-50%.
- Nuvama: Earnings could see a 24% reduction.
Market Response and Regulatory Uncertainty
Despite these potential impacts, BSE shares gained 2.70% to reach an intraday high of Rs 2,223.00 following reports that long-term F&O contracts are not on the agenda for Sebi's board meeting. The stock had previously fallen 8% in two sessions due to reports that the regulator was planning a consultation paper to end weekly expiries for futures and options contracts and shift to monthly expiry.
It's important to note that these projections are based on speculative changes to the derivative contract expiry cycles. SEBI has not yet provided any official confirmation regarding such modifications. The Sebi Chairman had previously indicated that the regulator sees a need to extend equity derivatives tenure and will issue a consultation paper on longer-duration F&O contracts, clarifying this is only a thought process requiring industry consultation.
Recent Regulatory Measures
The regulator has recently implemented measures including delta-based calculation of open interest and changes to market-wide position limits.
Next Steps
Jefferies has indicated that it will be closely monitoring SEBI's upcoming Board Meet, scheduled for Friday, for any clarification on these potential changes. The meeting could provide crucial insights into the regulator's stance on derivative expiry cycles and their potential impact on market participants.
Market Implications
If implemented, these changes could significantly alter the landscape for derivatives trading in India. The potential earnings impact on major players like BSE and Nuvama underscores the far-reaching consequences of regulatory decisions in the financial markets.
Investors and market participants are advised to stay tuned for any announcements from SEBI and to consider the potential implications of these changes on their investment strategies and market outlook.
As of the latest update, BSE shares were trading at Rs 2,218.00, up 2.56%, and have rallied over 65% in the last six months.
Historical Stock Returns for BSE
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
-0.52% | +1.64% | -11.88% | +59.04% | +69.27% | +3,383.84% |